Angelika Banzhoff

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. pmc Effective influenza vaccines for children: a critical unmet medical need and a public health priority
    Angelika Banzhoff
    Novartis Vaccines and Diagnostics, Marburg, Germany
    Hum Vaccin Immunother 8:398-402. 2012
  2. ncbi request reprint Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations
    Angelika Banzhoff
    Novartis Vaccines and Diagnostics, Marburg, Germany
    Hum Vaccin 7:539-48. 2011
  3. doi request reprint MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
    Angelika Banzhoff
    Novartis Vaccines, Marburg, Germany
    Influenza Other Respi Viruses 2:243-9. 2008
  4. pmc MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults
    Angelika Banzhoff
    Novartis Vaccines, Marburg, Germany
    PLoS ONE 4:e4384. 2009
  5. doi request reprint Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas
    Angelika Banzhoff
    Novartis Vaccines and Diagnostics GmbH and Co KG, Emil von Behring Strasse 76, 35041 Marburg, Germany
    Travel Med Infect Dis 6:331-41. 2008
  6. ncbi request reprint TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Olaf Zent
    Chiron Vaccines, Marburg, Germany
    Vaccine 23:312-5. 2004
  7. ncbi request reprint TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer
    Olaf Zent
    Chiron Vaccines, Marburg, Germany
    Int J Med Microbiol 293:134-8. 2004
  8. ncbi request reprint Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21)
    Ines Schoendorf
    Novartis Vaccines and Diagnostics, GmbH and Co KG, Marburg, Hessen 35041, Germany
    Hum Vaccin 3:42-7. 2007
  9. ncbi request reprint Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers
    Olaf Zent
    Clinical Research and Medical Affairs, Chiron Vaccines, Marburg, Germany
    J Travel Med 12:85-93. 2005
  10. ncbi request reprint Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule
    Olaf Zent
    Chiron Vaccines, Marburg, Germany
    Vaccine 21:4655-60. 2003

Detail Information

Publications14

  1. pmc Effective influenza vaccines for children: a critical unmet medical need and a public health priority
    Angelika Banzhoff
    Novartis Vaccines and Diagnostics, Marburg, Germany
    Hum Vaccin Immunother 8:398-402. 2012
    ..Based on the results of clinical studies in children, the use of MF59-adjuvanted vaccine offers the potential to enhance efficacy and make vaccination a viable prevention and control strategy in this population...
  2. ncbi request reprint Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations
    Angelika Banzhoff
    Novartis Vaccines and Diagnostics, Marburg, Germany
    Hum Vaccin 7:539-48. 2011
    ....
  3. doi request reprint MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
    Angelika Banzhoff
    Novartis Vaccines, Marburg, Germany
    Influenza Other Respi Viruses 2:243-9. 2008
    ..Similar results have been generated with a MF59-adjuvanted H5N1 pre-pandemic vaccine, which showed higher and broader immunogenicity compared with non-adjuvanted pre-pandemic vaccines...
  4. pmc MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults
    Angelika Banzhoff
    Novartis Vaccines, Marburg, Germany
    PLoS ONE 4:e4384. 2009
    ..Pathogenic avian influenza virus (H5N1) has the potential to cause a major global pandemic in humans. Safe and effective vaccines that induce immunologic memory and broad heterotypic response are needed...
  5. doi request reprint Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas
    Angelika Banzhoff
    Novartis Vaccines and Diagnostics GmbH and Co KG, Emil von Behring Strasse 76, 35041 Marburg, Germany
    Travel Med Infect Dis 6:331-41. 2008
    ..Efforts to develop internationally recognized recommendations for TBE vaccination for travellers are underway...
  6. ncbi request reprint TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Olaf Zent
    Chiron Vaccines, Marburg, Germany
    Vaccine 23:312-5. 2004
    ..To conclude, these results suggest that the administration of a further booster dose 3 years after the first one (according to current recommendations) does not seem to be necessary in this study population...
  7. ncbi request reprint TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer
    Olaf Zent
    Chiron Vaccines, Marburg, Germany
    Int J Med Microbiol 293:134-8. 2004
    ..A long lasting immunity can be concluded from the strong immune response following the booster immunization...
  8. ncbi request reprint Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21)
    Ines Schoendorf
    Novartis Vaccines and Diagnostics, GmbH and Co KG, Marburg, Hessen 35041, Germany
    Hum Vaccin 3:42-7. 2007
    ..To conclude, the rapid immunization schedule in children not only provides fast protection but also leads to stable titers as measured by NT for at least 300 days after vaccination...
  9. ncbi request reprint Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers
    Olaf Zent
    Clinical Research and Medical Affairs, Chiron Vaccines, Marburg, Germany
    J Travel Med 12:85-93. 2005
    ....
  10. ncbi request reprint Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule
    Olaf Zent
    Chiron Vaccines, Marburg, Germany
    Vaccine 21:4655-60. 2003
    ..A long lasting immunity can be concluded from the strong immune response following the first booster...
  11. ncbi request reprint Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine
    Claudius Malerczyk
    Clinical Research and Medical Affairs, Novartis Vaccines, Marburg, Germany
    J Travel Med 14:63-4. 2007
  12. ncbi request reprint A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis
    Angelika Banzhoff
    Clinical Research and Medical Affairs, Chiron Vaccines, Marburg, Germany
    Gerontology 49:177-84. 2003
    ..The elderly are at a higher risk of morbidity and mortality associated with influenza infection than younger adults, but get less protection from conventional vaccination...
  13. pmc A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly
    Elena Fragapane
    Novartis Vaccines and Diagnostics, Via Fiorentina, 1, 53100 Siena, Italy
    Clin Vaccine Immunol 17:1817-9. 2010
    ..2) H5N1 hemagglutinin, given approximately 18 months after primary vaccination with a heterologous strain, were evaluated. The booster vaccine was well tolerated and induced a robust, cross-reactive immune response...
  14. ncbi request reprint Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults
    Olaf Zent
    Chiron Vaccines, Marburg, Germany
    Vaccine 21:738-41. 2003
    ..To evaluate immunogenicity and safety of a polygeline-free tick-born encephalitis (TBE) vaccine in a clinical program...